Previous Article | Next Article ![]()
Eukaryotic Cell, February 2009, p. 161-169, Vol. 8, No. 2
1535-9778/09/$08.00+0 doi:10.1128/EC.00135-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Biochemistry, Weill Cornell Medical College, 1300 York Ave., New York, New York 10065
Received 15 April 2008/ Accepted 24 November 2008
|
|
|---|
cells. These data indicate that the cytoplasmic protein encoded by DET1 is involved in intracellular sterol transport. |
|
|---|
5- to 10-fold in the plasma membrane (PM) (30, 46); in the yeast Saccharomyces cerevisiae,
70% of total cellular ergosterol is located in the PM (3, 49). The mechanism by which sterols are transported between the ER and PM is poorly understood. Since the spontaneous diffusion of hydrophobic sterol molecules through an aqueous environment is thermodynamically unfavorable, cells must have a mechanism to transport sterols between membranes (33, 38). Studies with yeast and mammalian cells indicate that sterol transport between the ER and the PM does not depend on a functional vesicular transport pathway but requires ATP and is blocked at low temperatures (3, 18, 24, 29, 32, 45, 50). Proteins required for nonvesicular sterol transport between the ER and PM have not been identified convincingly (33, 38). There are numerous known sterol-binding proteins that could function in nonvesicular sterol transport, either directly as carriers or in an accessory role. Proteins with lipid-binding START domains (2) are attractive candidates for cytoplasmic sterol carriers. One member of the START family, the ceramide transporter CERT, was shown to catalyze the ATP-dependent transport of ceramide from the ER to the Golgi apparatus (14, 15). Recent structural analyses indicate that CERT specifically sequesters ceramide in a hydrophobic binding pocket to shield the lipid from the aqueous environment during transit through the cytoplasm (28). Targeting motifs within CERT enable it to engage the ER and Golgi apparatus specifically, providing a mechanism to restrict the ceramide transport pathway to these two organelles. Yeast cells lack proteins with START domains but contain other proteins with lipid-binding motifs. The seven oxysterol binding protein homologs, or Osh proteins (4), are prominent examples of soluble yeast proteins with putative lipid-binding domains. One of the Osh proteins, Osh4/Kes1, has been analyzed by X-ray crystallography in complex with different sterols (25) and shown to transport sterols between donor and acceptor vesicles in vitro (39). Elimination of the Osh proteins in particular combinations influences sterol transport in vivo (39, 49). However, it remains to be seen whether the true function of the Osh proteins is to transport sterols or to act in other ways, for example, as sterol sensors in regulating sterol distribution within the cell (10, 55).
A recent study attempted to identify proteins involved in sterol transport by using a visual screen for the transport-dependent accumulation of a fluorescent analog of cholesterol (40). The screen was limited to genes required for anaerobic growth. While the study discovered an unexpected role for mitochondria in PM-ER sterol transport, it did not identify a sterol transporter. Here we report a tritium suicide selection strategy designed to identify yeast mutants with defects in sterol transport, thus providing an unbiased way to identify components of the nonvesicular sterol transport system. The selection operates on the premise that cells that are unaffected in a function/pathway of interest will accumulate large amounts of a tritiated substrate, whereas those with defects in that function or pathway will not. When a mutagenized culture of cells is incubated with an appropriate tritium-labeled substrate and stored at –80°C, cells that efficiently accumulate the radiolabeled probe undergo radiation-induced DNA damage and die, leaving behind an enriched pool of mutants.
We exploited the transport-dependent accumulation of exogenous [3H]cholesterol in Upc2-1 cells mutagenized with a transposon library, in conjunction with tritium suicide selection, to uncover mutants defective in the incorporation of exogenous sterols. Analysis of the survivors uncovered numerous genes involved in the uptake and transport of exogenous sterols. We identified the transcription factor Mot3 as a repressor of AUS1 and PDR11, genes that encode PM-localized ATP-binding cassette (ABC) transporters involved in sterol uptake. We also identified the previously uncharacterized open reading frame (ORF) Ydr051c, which we now refer to as DET1 (decreased ergosterol transport). Transport of sterols between the ER and PM was significantly reduced in det1
cells, indicating that the cytoplasmic protein encoded by DET1 is involved in intracellular sterol transport.
|
|
|---|
Growth conditions, cloning, and common techniques.
Strains used in this study are listed in Table 1. Unless otherwise stated, yeast cultures were grown in a rich medium (YPD; 1% [wt/vol] yeast extract, 2% [wt/vol] peptone, 2% [wt/vol] glucose) with shaking at 250 rpm at 25°C. Strains carrying plasmids were grown under selective conditions in synthetic media. Growth of cells in suspension was monitored by the optical density at 600 nm (OD600). DNA cloning and bacterial and yeast transformations were carried out using standard techniques (13, 44). To clone MOT3, DNA was amplified from WPY361 genomic DNA using PCR and primers with engineered restriction sites for XhoI and HindIII. Primers were designed to include the entire ORFs and
1,000 bp of the 5' untranslated region (UTR). The digested product was ligated into pRS316 and confirmed by sequencing. Aus1-GFP and Pdr11-GFP were expressed as C-terminal fusion proteins under the control of their endogenous promoters from the plasmids pWP1220 and pWP1251, respectively (32).
|
View this table: [in a new window] |
TABLE 1. Strains used in this study
|
15,000 from each pool). Transformants from each pool were subjected to selection separately. Suspensions of the transformants obtained by recovering the colonies in sterile water were used to inoculate overnight cultures. The following day, the cultures were diluted to 0.25 OD600 unit/ml in 50 ml and allowed to undergo one doubling. Twenty-five OD600 units of these cultures was harvested, resuspended in 250 µl YPD, and incubated at 37°C for 15 min. A total of 10 OD600 units (100 µl) was collected, resuspended in YPD containing 1 mCi of [3H]cholesterol in 4% (vol/vol) Tween 80-ethanol (1:1 [vol/vol]), and vortexed vigorously. A parallel control sample of cells was resuspended similarly, except that unlabeled cholesterol was used. The samples were incubated at 37°C for 1 h, after which the cells were collected, washed thrice with ice-cold water, and resuspended in 1 ml of ice-cold water. Aliquots of cells were removed to determine cell number (by plating serial dilutions) as well as the extent of [3H]cholesterol uptake and conversion to cholesteryl ester (see below). The remaining cells were diluted with an equal volume of 20% (vol/vol) glycerol, divided into 50-µl aliquots, and stored at –80°C. Aliquots were periodically removed, and serial dilutions were plated to determine cell survival. When the survival rate approached a minimum, the remaining aliquots were removed and plated on YPD at a density of
100 colonies per plate. Cholesterol uptake on these plates was analyzed as described below. To ensure that mutants with temperature-sensitive defects were not missed, the survivors were assayed for the ability to incorporate sterols at 37°C. The site of transposon insertion was determined using EcoRI to digest genomic DNA and standard protocols associated with the library (6). The recovered mutants discussed here were all verified by Southern blot analysis or by recreating the disruption in Upc2-1 to ensure that the defects observed were caused by a single insertion in the indicated ORF. The probe for Southern blot analysis of the EcoRI-digested genomic DNA was created using PCR and the primers ACC TGC GTT TCA CCC TGC CAT AAA GA and ACC CAA CTT AAT CGC CTT GCA GCA CA, which recognize a portion of the lacZ gene in the insert backbone. This PCR product was labeled using random primer extension and [32P]CTP. Uptake of cholesterol by yeast on plates. To assess cholesterol uptake of multiple colonies simultaneously, the protocol of Lewis et al. (31) was used. Briefly, colonies were spotted onto YPD plates, grown for 2 days at room temperature, and then replica plated onto a YPD plate overlaid with a nitrocellulose disc. After allowing the cells to grow for 2 days at room temperature, the disc was overlaid onto a YPD plate containing 1% (vol/vol) Tween 80-ethanol (1:1 [vol/vol]) and 0.5 µCi/ml [14C]cholesterol. After 4 h, the disc was removed and treated to remove nonspecifically bound [14C]cholesterol. This was accomplished by first placing the disc with the colony side up on Whatman paper soaked with 0.5% (wt/vol) NP-40 and then on dry paper towels. After repeating the treatment thrice, the colonies on the disc were transferred to Whatman paper by pressing the two together in a sandwich of paper towels. The disc was removed, and the Whatman paper was wrapped in plastic wrap and exposed to a phosphorimager plate overnight to visualize [14C]cholesterol uptake by the individual colonies.
Uptake of cholesterol by cells in suspension. Measurement of cholesterol uptake by suspension-grown yeast cells was done by a procedure adapted from the work of Li and Prinz (32). Briefly, overnight cultures were diluted to 0.5 OD600 unit/ml in 2 ml of YPD. After 2 h (roughly one doubling period), the cultures were shifted to 37°C and preincubated for 15 min before adding a mixture of cholesterol and [3H]cholesterol in 1:1 (vol/vol) Tween 80-ethanol. The final concentration (each) of Tween 80 and ethanol was 0.5% (vol/vol), and the final concentration of cholesterol was 1 µM, with 10 µCi of [3H]cholesterol. After incubation at 37°C for 1 h, 1.5 ml of each culture was removed and collected. Cell pellets were washed three times with 1 ml ice-cold 0.5% (vol/vol) Tween 80 in water and then resuspended in 200 µl ice-cold water. Acid-washed glass beads (200 µl) were added, and the cells were disrupted by being vortexed (six times for 30 s each, interspersed with 30-s cooling periods on ice). The resulting cell homogenate was collected, and the beads were washed with 800 µl of water. The homogenate and wash were combined and then extracted with 3 ml of hexanes-isopropanol (3:2 [vol/vol]). After thorough mixing of the sample, the organic phase was allowed to separate and then recovered and replaced with 2 ml of hexanes. The combined organic phases were dried and dissolved in 100 µl of chloroform-methanol (1:1 [vol/vol]), from which 10 µl was removed for scintillation counting to determine the total amount of radioactivity taken up by the cells and 35 µl was analyzed by thin-layer chromatography (TLC) to quantify the amount of label incorporated into cholesteryl esters and free cholesterol. For TLC, the samples were spotted onto silica gel 60 plates and resolved using hexanes-diethyl ether-acetic acid (70:30:1 [vol/vol/vol]) as the solvent system. Free cholesterol and cholesteryl esters had Rf values of 0.15 and 0.75, respectively. The relative amounts of radioactivity in the peaks were quantitated using a Berthold LB2842 TLC scanner.
Transport of ergosterol from the ER to the PM. Transport assays were done as described by Baumann et al. (3) at 37°C with a 15-min preincubation in prewarmed medium. Briefly, cells were pulse labeled with [3H-methyl]methionine and then chased. Aliquots were removed at different time points and incubated with MβCD on ice to extract PM ergosterol. Ergosterol in the MβCD extract, as well as that in the cell sample, was quantitated by organic solvent extraction and high-performance liquid chromatography (HPLC) analysis. Fractions were collected and taken for scintillation counting to determine the amount of [3H]ergosterol, whereas bulk ergosterol was quantitated by an in-line UV detector set at 280 nm. The specific radioactivity (SR) of [3H]ergosterol was determined in each case, and the SR of the MβCD sample was normalized to the SR of the cell sample to determine relative specific radioactivity (RSR) (RSR = SRMβCD extract/SRcell). The RSR directly compares the specific radioactivity of PM-localized ergosterol extracted by MβCD with that of total cellular ergosterol; plots of RSR versus time provide a measure of the rate at which ergosterol is transported from the ER to the PM.
Subcellular distribution of ergosterol.
Total membranes from
20 OD600 units of cells (grown to an OD600 of
1 at room temperature and then incubated for 15 min at 37°C prior to homogenization) were fractionated on step gradients of RenoCal-76 exactly as described previously (3, 7, 32). Sterol content in the pooled intracellular and PM fractions (identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis immunoblotting using organelle-specific antibodies) was determined using reverse-phase HPLC as described above. Sterol/phospholipid ratios were determined from lipid extracts obtained by hot ethanol extraction (16) and desalted by n-butanol-water partitioning. Sterol was quantitated using HPLC as described below, and lipid phosphorus was quantitated exactly as described previously (43).
QPCR. Overnight cultures were diluted to 0.5 OD600 unit/ml and incubated for 2 h at 25°C. Cells were harvested, transferred to prewarmed YPD, and incubated at 37°C for 45 min. RNA was isolated from 2 OD600 units of cells by use of an RNeasy Mini kit (Qiagen), following the protocol for mechanical disruption of cells using glass beads. cDNA was prepared using Brilliant SYBR green QRT-PCR AffinityScript two-step master mix (Stratagene) following the provided protocol. Quantitative PCR (QPCR) amplification of cDNA was performed using the same kit according to the manufacturer's protocol. The primers used are listed in Table 2. QPCR was carried out using Stratagene's MX3005P and MX4000 QPCR systems. The thermal profile was as follows: 10 min at 95°C and 40 cycles of 30 s at 95°C, 1 min at 50°C, and 30 s at 72°C. Fluorescence readings were taken at the end of each 50°C annealing cycle. A melting curve from 50°C to 95°C was performed in each experiment after the last cycle to determine the specificity of the primers for a single sequence. Data were analyzed using Stratagene's MxPro software and normalized to ACT1 mRNA levels.
|
View this table: [in a new window] |
TABLE 2. Primers used in this study
|
All images were acquired at a magnification of x63, using an oil immersion lens on a Zeiss Axiovert 200 wide-field microscope equipped with a MicroMax interline charge-coupled device camera driven by MetaMorph Imaging System software (Universal Imaging Corp.). Images were taken with the same exposure times and processed to maintain intensity differences using Adobe Photoshop CS2 (Adobe Systems, Mountain View, CA).
|
|
|---|
When Upc2-1 cells are supplied with [3H]cholesterol, they convert it efficiently to [3H]cholesteryl esters that accumulate in lipid droplets (32). It is likely that the exogenously supplied sterol is first incorporated into the PM via a mechanism involving Dan1, Aus1, and Pdr11 and then transported to the ER, where it is esterified by the ER-localized yeast acyl-coenzyme A cholesterol acyl transferases Are1 and Are2 (56) (Fig. 1A). The cellular accumulation of cholesterol is strongly dependent on esterification, such that in the absence of Are1 and Are2, the total amount of internalized cholesterol is low (32). In contrast to cholesterol, exogenously supplied ergosterol is poorly esterified since it remains localized to the PM (see Discussion) (32).
![]() View larger version (27K): [in a new window] |
FIG. 1. [3H]cholesterol suicide selection. (A) Schematic illustration showing the uptake, PM-ER transport, and accumulation of cholesterol in the form of cholesteryl ester in a Upc2-1 cell. (B) Killing curve. Upc2-1 cells were mutagenized with a transposon library. After outgrowth, 8 x 106 cells were either loaded with [3H]cholesterol or mock treated with nonlabeled cholesterol. Aliquots of the cells were frozen and stored at –80°C. At the indicated times, aliquots were removed from the freezer, thawed, and plated to determine the number of surviving colonies. The graph shows the percent survival of 3H-loaded and mock-treated cells after storage at –80°C. (C) Colonies that survived the suicide selection were gridded, replica plated onto nitrocellulose paper, and overlaid on agar containing [14C]cholesterol. After incubation, colony-associated radioactivity was visualized with a phosphorimager. Open arrowheads indicate examples of colonies with decreased uptake that were picked for further study.
|
10 cpm/cell. The culture was washed, divided into aliquots, and frozen at –80°C. A parallel sample was loaded with unlabeled cholesterol and treated similarly. During cold storage, cells that internalize a significant amount of the [3H]cholesterol are predicted to accumulate radiation-induced DNA damage and die. In contrast, mutants with defects in sterol accumulation, including cells with defects in PM-ER sterol transport, are likely to survive. To check the survival of the culture, aliquots of cells were removed periodically, and the number of survivors was determined by plating serial dilutions. The proportion of viable cells in the control culture remained relatively constant, at
30% (Fig. 1B). As predicted, the [3H]cholesterol-loaded sample showed a dramatic decrease in survival, with only
0.05% of the cells remaining after 80 days (Fig. 1B). At this point, the remaining aliquots of the loaded culture were removed from the freezer and plated on YPD; 4,000 survivors were recovered from an initial load of 8 x 106 cells. The survivors were screened for the ability to incorporate exogenous cholesterol. Colonies were transferred from solid medium to a nitrocellulose disc that was then overlaid onto a [14C]cholesterol-containing plate; after a period of incubation, the disc was removed and washed, and the extent of [14C]cholesterol uptake was visualized with a phosphorimager (Fig. 1C). Based on this assay, a total of 364 mutants from both pools of the mTn3 library had a defect in sterol uptake, as defined by a decreased ability to incorporate sterols at 37°C, although the mutants varied dramatically in the extent of the defect. The site of transposon insertion in the mutants was identified as described previously (42). The mutant collection was screened until multiple hits were recovered in some of the different ORFs. We used Southern analysis (or recreation of the gene disruption, if necessary) to verify that the defect in sterol accumulation in the mutants was due to the disruption of a single gene. Through this process, we identified 23 nonessential genes with a putative role in sterol transport (Table 3). Disruptions in UPC2, RDN25-1, TVP18, and the YDR051c gene were observed at greater frequencies than disruptions in the other ORFs listed in Table 3. Because Upc2-1 is critical for sterol uptake in this strain, the recovery of insertions that disrupted the UPC2 locus was expected and confirmed the validity of our approach.
|
View this table: [in a new window] |
TABLE 3. Genes involved in transport-dependent accumulation of exogenous sterols
|
To confirm that the 14 mutants corresponding to these two categories were defective in accumulating exogenously supplied sterol, we determined cholesterol uptake using suspension-grown cells. This provides a quantitative complement to the more qualitative filter uptake assay used in our initial screen. Exponentially growing cultures of the 14 mutants were incubated for 60 min with 1 µM cholesterol and a trace amount of [3H]cholesterol. Relative to the parent Upc2-1 strain, all mutants had a decreased ability to accumulate exogenous sterols (Fig. 2A). Six of the mutants, those with inserts in AIM44, HOF1, RAM1, TVP18, SCY1, and the YDR051c gene (which we henceforth refer to as DET1 [decreased ergosterol transport]), had significantly reduced accumulation that approached the level of a wild-type strain (BY4741) that lacks the ability to take up exogenous sterols because of aerobic sterol exclusion. Of the small amount of sterol that was taken up by these six mutants, a significant portion (50 to 90%) in all strains was esterified to cholesteryl ester, as determined by separating and quantitating the incorporated [3H]cholesterol by TLC (Fig. 2B). These data suggest that the poor accumulation of [3H]cholesterol in the six mutants was not due to defective esterification.
![]() View larger version (15K): [in a new window] |
FIG. 2. Quantitative assay of sterol incorporation by a subset of suicide selection survivors. (A) Logarithmically growing cultures of isolates from the suicide selection were incubated in YPD with 1 µM cholesterol (containing 10 µCi [3H]cholesterol) in 0.5% (wt/vol) ethanol-0.5% (wt/vol) Tween 80 for 60 min at 37°C. Cells were recovered, washed, and lysed. The incorporation of [3H]cholesterol was determined by scintillation counting and extrapolated to the amount of bulk cholesterol uptake in the culture. The graph shows the averages and variances for two independent experiments. (B) Lysed cells from panel A were taken for lipid extraction; free cholesterol and cholesteryl esters in the extract were resolved by TLC and quantitated as described in Materials and Methods.
|
70% at 37°C) relative to that in the Upc2-1 strain. Our results suggest that the insertion of a transposon into the TVP18 locus increased the level of MOT3 mRNA, resulting in a transcriptionally mediated decrease in ABC transporter expression and a concomitant decrease in sterol uptake. Indeed, analysis of the promoter regions of both AUS1 and PDR11 indicates numerous putative Mot3 binding sites and suggests that AUS1 and PDR11 can be included in the list of known anaerobic genes that are repressed by Mot3.
![]() View larger version (14K): [in a new window] |
FIG. 3. Effect of Mot3 on expression of Aus1 and Pdr11. Logarithmically growing cultures of the Upc2-1 strain, a mutant with a transposon insertion in the TVP18 locus, and Upc2-1 cells transformed with a single-copy plasmid containing MOT3 (pMOT3) were preincubated at 37°C for 45 min. Cells were recovered, and RNAs were extracted and transcribed into DNA as described in Materials and Methods. After cDNA synthesis, the levels of mRNA corresponding to MOT3, AUS1, and PDR11 were determined using QPCR. Data (normalized to results for the Upc2-1 strain) show the averages and variances for two separate experiments.
|
![]() View larger version (47K): [in a new window] |
FIG. 4. Aus1-GFP and Pdr11-GFP localization. Mutants from the suicide selection were transformed with single-copy vectors bearing either AUS1-GFP or PDR11-GFP under the control of endogenous promoters. The strains were grown to mid-logarithmic phase in synthetic media lacking the appropriate nutrient and visualized using wide-field fluorescence microscopy. Images were generated under the same settings and processed identically. Representative cells are shown. Bar = 10 µm.
|
cells.
Since ergosterol transport between the ER and the PM occurs via a bidirectional process (3), we hypothesized that cells lacking DET1 would be defective in biosynthetic sterol transport. To test this, we assayed transport of newly synthesized ergosterol from the ER to the PM in det1
cells obtained from the yeast nonessential gene deletion collection (54). Ergosterol was pulse labeled in the ER, using [3H-methyl]methionine, and then chased with medium containing unlabeled methionine. Arrival of [3H]ergosterol at the PM was measured by withdrawing an aliquot of cells and sampling PM sterol by extraction with MβCD. Ergosterol in both the MβCD extract and the corresponding cells was quantitated using reverse-phase HPLC. Radioactivity in the fractions corresponding to ergosterol was measured using scintillation counting to determine the SR in the sample. The RSR of ergosterol in the MβCD extract (the ratio of the SR in the MβCD extract to SR in the corresponding cell sample) was plotted against time to generate a transport curve (Fig. 5). ER-to-PM transport was significantly reduced in det1
cells: the initial rate of transport (determined from the linear portion [0 to 5 min] of a mono-exponential fit to the data) was reduced threefold in det1
cells relative to that in the parent strain BY4741. The cumulative data indicate that Det1 is involved, either directly or indirectly, in the bidirectional transport of sterols between the ER and the PM.
![]() View larger version (20K): [in a new window] |
FIG. 5. Sterol transport in det1 cells. Sterol transport in BY4741 (parent) and det1 cells was measured by using MβCD to monitor the arrival of metabolically labeled ergosterol at the PM in a pulse-chase experiment as described in Materials and Methods. The RSR of [3H]ergosterol in the MβCD extract was quantitated and graphed versus chase time. The lines represent mono-exponential fits of data averaged from at least two independent experiments. Error bars represent standard deviations.
|
cells grew slightly more slowly than the BY4741 parent strain but otherwise appeared normal, as judged by (i) transmission electron microscopy of negatively stained samples, (ii) calcofluor white staining (to detect cell wall defects), and (iii) uptake of the fluorescent lipophilic dye FM4-64 (to assess bulk endocytosis) (not shown). Since a sterol transport defect could lead to changes in sterol content and intracellular distribution, we examined these properties of det1
cells (5, 11). Nile red staining showed a normal distribution of lipid droplets (Fig. 6A), with 2.6 ± 1.1 and 2.5 ± 1.2 lipid droplets per cell for det1
and BY4741 cells, respectively (mean ± standard deviation [SD]; >300 cells from each strain were examined). Similar results were obtained in a comparison of C209 and Upc2-1 cells. Lipid analysis of cells grown to mid-logarithmic phase showed the same ergosterol/phospholipid molar ratio in det1
and BY4741 cells (0.187 ± 0.001 and 0.191 ± 0.019 for det1
and BY4741 cells, respectively [mean ± SD of duplicate measurements from two independent experiments]). We analyzed the subcellular distribution of ergosterol by using RenoCal gradients to separate the PM from other intracellular membranes in a cell homogenate. The quality of separation was assessed by immunoblotting with organelle-specific antibodies (Fig. 6B). Ergosterol in the separate pooled fractions was extracted with organic solvents and quantified using HPLC. The localization of ergosterol in det1
cells was nearly identical to that in the parent strain, with
70% of the total sterol present at the PM (Fig. 6C).
![]() View larger version (62K): [in a new window] |
FIG. 6. Lipid droplets and subcellular distribution of ergosterol in det1 cells. (A) Lipid droplets in BY4741 (parent) and det1 cells were visualized by fluorescence microscopy after Nile red staining. Bar = 10 µm. (B) Fractionation of a BY4741 cell homogenate on a discontinuous RenoCal gradient as described in Materials and Methods. Fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis immunoblotting, using antibodies against the PM (Gas1), vacuole (Vph1), ER (sec61), and Golgi complex/endosome (Pep12). Fractions 1 to 8, corresponding to intracellular membranes, and fractions 9 to 14, corresponding to the PM, were pooled and taken for lipid analysis. (C) Percentages of total ergosterol recovered in PM pools isolated from BY4741 and det1 cells.
|
|
|
|---|
Figure 1A envisages three steps in the accumulation of exogenously supplied cholesterol. C209 (det1::mTn3) cells esterify cholesterol similarly to parental Upc2-1 cells and display a normal pattern of expression of Aus1 and Pdr11 (Fig. 4), suggesting that the defect in these cells is in the step of sterol transport between the ER and PM rather than in sterol uptake at the PM or sterol esterification. In support of this, assays of biosynthetic sterol transport in det1
cells revealed that transport of newly synthesized ergosterol from the ER to the PM was slowed threefold compared to that in parental BY4741 cells (Fig. 5).
Sequence analysis of the det1::mTn3 mutant showed that transposon insertion occurred between chromosomal coordinates 557748 and 557749 on chromosome IV, allowing for the production of a truncated protein corresponding to the first 104 amino acids of Det1. Preliminary results indicated that this truncated protein acts in a dominant-negative way to inhibit sterol uptake (not shown), potentially accounting for the severity of the defect (
20-fold) in the rate of sterol accumulation in C209 cells (Fig. 2) compared with the milder defect (
3-fold reduction) in the rate of biosynthetic sterol transport in det1
cells (Fig. 5).
How might Det1 play a role in nonvesicular sterol transport? Det1 is an
39-kDa soluble protein with a predicted abundance of
3,000 molecules per cell (20). GFP-tagged Det1 is localized primarily to the cytoplasm (12, 23), consistent with a role in sterol transport across the cytoplasm. Sequence analysis shows that Det1 has significant similarity to phosphoglycerate mutases. However, Det1 lacks a number of residues shown to be critical for catalysis (51, 52), and this activity (as performed by Gpm1, Gpm2, and/or Gpm3) in S. cerevisiae has been well characterized (17, 41). Other than the predicted similarity to phosphoglycerate mutases, sequence analysis reveals that Det1 has a number of close homologs in other fungi (i.e., KLLA0F18810g in Kluyveromyces lactis and ca5949 in Candida albicans) but no clear homologs in mammals. Perhaps Det1 is involved in a yeast-specific or ergosterol-specific aspect of sterol transport or significant sequence divergence has occurred in the course of evolution of the more complex cholesterol regulatory mechanisms in higher eukaryotes. While the identification of Det1 as an important player in intracellular sterol transport opens the door to future studies on this poorly understood process, more analyses are required in order to determine the exact nature and mechanism of its involvement.
This work was supported by NIH grant GM55427 (to A.K.M.).
Published ahead of print on 5 December 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»